12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in healthcare stocks on Thursday. Longeveron, BioRestorative Therapies, Aethlon Medical, Sharps Technology, Biomea Fusion, and iSpecimen saw notable gains, while Assure Holdings, CERo Therapeutics Holdings, Cara Therapeutics, Kronos Bio, Cyclerion Therapeutics, and Petros Pharma experienced declines.

June 13, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aethlon Medical shares rose 26.84% to $0.66, with a market cap of $3.3 million.
The sharp increase in share price indicates a positive market reaction, possibly due to favorable news or developments.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Biomea Fusion stock increased by 20.95% to $5.6, with a market cap of $201.2 million.
The significant price increase indicates strong investor interest, possibly due to positive news or developments.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
BioRestorative Therapies stock rose 27.4% to $1.72, with a market cap of $11.6 million.
The significant price increase suggests positive sentiment or news driving the stock higher.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
iSpecimen shares rose 20.66% to $0.41, with a market cap of $4.1 million.
The notable price increase suggests positive investor sentiment or news impacting the stock.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Longeveron stock surged by 74.6% to $3.16, significantly increasing its market cap to $20.0 million.
The substantial increase in stock price indicates strong investor interest and potential positive developments.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Sharps Technology stock moved up by 23.58% to $0.37, with a market cap of $6.5 million.
The notable price increase suggests positive investor sentiment or news impacting the stock.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Cara Therapeutics stock declined by 35.97% to $0.44, with a market cap of $23.7 million.
The sharp decline in stock price indicates negative investor sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
CERo Therapeutics Holdings stock decreased by 40.28% to $0.42, with a market cap of $6.3 million.
The significant price drop suggests negative news or developments impacting the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Cyclerion Therapeutics stock fell 13.66% to $1.96, with a market cap of $4.8 million.
The notable price decrease suggests negative investor sentiment or news impacting the stock.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Assure Holdings stock fell 47.6% to $0.27, with a market cap of $2.4 million, following Q1 earnings release.
The sharp decline in stock price is likely due to disappointing Q1 earnings, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Kronos Bio shares decreased by 15.63% to $1.08, with a market cap of $64.9 million.
The notable price decrease suggests negative investor sentiment or news impacting the stock.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Petros Pharma shares fell 12.61% to $0.47, with a market cap of $3.2 million.
The notable price decrease suggests negative investor sentiment or news impacting the stock.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100